Economic outcomes of exenatide vs liraglutide in type 2 diabetes patients in the United States: results from a retrospective claims database analysis

Current Status Of Comorbid Depression Among Japanese Type 2 Diabetes Patients Based On Claims Database Analysis

Value in Health ◽

10.1016/j.jval.2016.03.1385 ◽

2016 ◽

Vol 19 (3) ◽

pp. A182

Author(s):

T Takeshima ◽

K Iwasaki ◽

A Uda ◽

S Hiroi ◽

Y Shimasaki

Keyword(s):

Type 2 Diabetes ◽

Current Status ◽

Comorbid Depression ◽

Database Analysis ◽

Claims Database ◽

DM2 ADHERENCE TO DPP-4 INHIBITORS VERSUS PIOGLITAZONE IN TYPE 2 DIABETES PATIENTS WITH CHRONIC KIDNEY DISEASE: A RETROSPECTIVE CLAIMS DATABASE ANALYSIS

Value in Health ◽

10.1016/j.jval.2019.04.040 ◽

2019 ◽

Vol 22 ◽

pp. S39

Author(s):

D. Gor ◽

T.A. Lee ◽

G. Schumock ◽

S.M. Walton ◽

B. Gerber ◽

...

Keyword(s):

Type 2 Diabetes ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Database Analysis ◽

Claims Database ◽

Real-World Clinical and Economic Outcomes of Liraglutide Versus Sitagliptin in Patients with Type 2 Diabetes Mellitus in the United States

Diabetes Therapy ◽

10.1007/s13300-014-0084-9 ◽

2014 ◽

Vol 5 (2) ◽

pp. 579-590 ◽

Cited By ~ 12

Author(s):

Qian Li ◽

Abhishek Chitnis ◽

Mette Hammer ◽

Jakob Langer

Keyword(s):

Diabetes Mellitus ◽

United States ◽

Type 2 Diabetes ◽

Real World ◽

The United States ◽

Economic Outcomes

A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the united states from 2003 to 2005

Clinical Therapeutics ◽

10.1016/j.clinthera.2010.07.011 ◽

2010 ◽

Vol 32 (7) ◽

pp. 1308-1319 ◽

Cited By ~ 36

Author(s):

Richard A. Hansen ◽

Joel F. Farley ◽

Marcus Droege ◽

Matthew L. Maciejewski

Keyword(s):

Diabetes Mellitus ◽

United States ◽

Type 2 Diabetes ◽

Cohort Study ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

The United States ◽

Economic Outcomes

Characteristics, Treatment Patterns, and Economic Outcomes of Patients Initiating Injectable Medications for Management of Type 2 Diabetes Mellitus in Japan: Results from a Retrospective Claims Database Analysis

Diabetes Therapy ◽

10.1007/s13300-018-0407-3 ◽

2018 ◽

Vol 9 (3) ◽

pp. 1125-1141

Author(s):

Shuichi Suzuki ◽

Urvi Desai ◽

Alena Strizek ◽

Jasmina Ivanova ◽

Viviana Garcia-Horton ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Treatment Patterns ◽

Economic Outcomes ◽

Database Analysis ◽

Claims Database

Adherence and Persistence with DPP-4 Inhibitors Versus Pioglitazone in Type 2 Diabetes Patients with Chronic Kidney Disease: A Retrospective Claims Database Analysis

Journal of Managed Care & Specialty Pharmacy ◽

10.18553/jmcp.2020.26.1.67 ◽

2020 ◽

Vol 26 (1) ◽

pp. 67-75 ◽

Cited By ~ 1

Author(s):

Deval Gor ◽

Todd A. Lee ◽

Glen T. Schumock ◽

Surrey M. Walton ◽

Ben S. Gerber ◽

...

Keyword(s):

Type 2 Diabetes ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Database Analysis ◽

Claims Database ◽

The Effect of Early Response to GLP-1 RA Therapy on Long-Term Adherence and Persistence Among Type 2 Diabetes Patients in the United States

Journal of Managed Care & Specialty Pharmacy ◽

10.18553/jmcp.2019.18429 ◽

2019 ◽

Vol 25 (6) ◽

pp. 669-680

Author(s):

Emily Durden ◽

Michael Liang ◽

Robert Fowler ◽

Ulrik Haagen Panton ◽

Emina Mocevic

Keyword(s):

United States ◽

Type 2 Diabetes ◽

Early Response ◽

The United States ◽

Clinical Outcomes of Concomitant Therapy of Exenatide Twice Daily and Basal Insulin in Patients with Type 2 Diabetes Mellitus: A Retrospective Database Analysis in the United States

Endocrine Practice ◽

10.4158/ep11367.or ◽

2012 ◽

Vol 18 (5) ◽

pp. 700-711 ◽

Cited By ~ 5

Author(s):

Manjiri Pawaskar ◽

Qian Li ◽

Byron Hoogwerf ◽

Matthew Reynolds ◽

Lauren Lee ◽

...

Keyword(s):

Diabetes Mellitus ◽

United States ◽

Type 2 Diabetes ◽

The United States ◽

Concomitant Therapy ◽

Database Analysis ◽

Retrospective Database Analysis ◽

Retrospective Database

Effect of Weight Change on Economic Outcomes Among Persons with Type 2 Diabetes Mellitus in the United States: Beyond Glycemic Control

Journal of Managed Care & Specialty Pharmacy ◽

10.18553/jmcp.2019.18321 ◽

2019 ◽

Vol 25 (6) ◽

pp. 658-668 ◽

Cited By ~ 2

Author(s):

Swapna Karkare ◽

Moshe Fridman ◽

Tam Dang-Tan ◽

Jingsong Lu ◽

B. Gabriel Smolarz ◽

...

Keyword(s):

Diabetes Mellitus ◽

United States ◽

Type 2 Diabetes ◽

Glycemic Control ◽

Weight Change ◽

The United States ◽

Economic Outcomes

Budget impact of treating commercially insured type 1 and type 2 diabetes patients in the United States with insulin degludec compared to insulin glargine

Current Medical Research and Opinion ◽

10.1080/03007995.2016.1251893 ◽

2016 ◽

Vol 33 (2) ◽

pp. 231-238 ◽

Cited By ~ 2

Author(s):

James Weatherall ◽

Lisa Bloudek ◽

Sarah Buchs

Keyword(s):

United States ◽

Type 2 Diabetes ◽

Insulin Glargine ◽

Budget Impact ◽

The United States ◽

Insulin Degludec ◽